Novus Biologicals ATG16L1 Peptide
Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition
Manufacturer: Novus Biologicals NBP176862PEP
DescriptionA blocking peptide containing 18 amino acids near the amino terminus of human ATG16. Source: Synthetic (Accession #: NP_110430) The ATG16L1 Blocking Peptide has been validated for the following applications: Antibody Competition.
|For Blocking the binding of NBP1-76862|
|PBS pH 7.2 (10mM NAH2PO4, 10mM Na2HPO4, 130mM NaCl) containing 0.1% bovine serum albumin.|
|18 amino acids near the amino terminus of human ATG16|
|−20°C. Avoid freeze-thaw cycles.|